Method of treating inflammation disorders using extracts of passion fruit

(19)

(11)

EP 1 854 470 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	19.05.2010 Bulletin 2010/20

(45)	Mention of the grant of the patent:
	03.03.2010 Bulletin 2010/09

(21)	Application number: 07251879.8

(22)	Date of filing: 04.05.2007

(51)

International Patent Classification (IPC):

A61K 36/185^(2006.01)
A61P 11/06^(2006.01)
A61P 11/00^(2006.01)

A61P 29/00^(2006.01)
A61P 19/02^(2006.01)

(54)	Method of treating inflammation disorders using extracts of passion fruit Verfahren zur Behandlung von Entzündungserkrankungen mit Maracujaextrakten Procédé pour le traitement de troubles inflammatoires à base d'extraits de fruit de la passion

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30)

Priority:

04.05.2006 US 417721

(43)	Date of publication of application:
	14.11.2007 Bulletin 2007/46

(73)	Proprietors:
	Industrial Research Limited, L.L.C. Auckland 1033 (NZ) Southwest Scientific Editing & Consulting, L.L.C. Tucson, AZ 85749 (US)

(72)	Inventors:
	Foo, Lai Yeap Lower Hutt (NZ) Lu, Yinrong Lower Hutt (NZ) Watson, Ronald Ross Tucson, Arizona 85749 (US)

(74)	Representative: Evans, Jacqueline Gail Victoria et al
	Greaves Brewster LLP Indigo House Cheddar Business Park Wedmore Road Cheddar, Somerset BS27 3EB Cheddar, Somerset BS27 3EB (GB)

(56)

References cited: :

WO-A-2005/097153

FRODE T S ET AL: "Anti-inflammatory effects of Passiflora edulis Sims on the mouse model of pleurisy induced by carrageenan" CLINICAL CHEMISTRY, vol. 50, no. 6, Suppl. S, Part 2, June 2004 (2004-06), pages A36-A37, XP002445818 & 56TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY (AACC); LOS ANGELES, CA, USA; JULY 25-29, 2004 ISSN: 0009-9147
FRODE T S ET AL: "Species of Passiflora inhibit markers of inflammation in a marine model" CLINICAL CHEMISTRY, vol. 51, no. Suppl. 6, 2005, page A208, XP001536631 & ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CLINICAL-CHEMISTR Y; ORLANDO, FL, USA; JULY 24 -28, 2005 ISSN: 0009-9147
SHERMA ZIBADI ET AL: "Passion Fruit (Passiflora edulis). Composition, Efficacy and Safety" EVIDENCE - BASED INTEGRATIVE MEDICINE, ADIS INTERNATIONAL, AUCKLAND, NZ, vol. 1, no. 3, 2004, pages 183-187, XP007902754 ISSN: 1176-2330

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).